Literature DB >> 35111647

Quantification of peripapillary vessel density in non-arteritic anterior ischemic optic neuropathy patients with optical coherence tomography angiography.

Yufang Su1, Song Zhang2, Guisen Zhang3, Yingru Liu1, Zhiguo Du1, Daming Li4, Lei Liu5,6,7.   

Abstract

BACKGROUND: Quantitative assessments based on optical coherence tomographic angiography (OCTA) may have potential promising value in the early detection of non-arteritic anterior ischemic optic neuropathy (NA-AION), but there is limited information on the ability of OCTA to distinguish eyes with NA-AION. This study was conducted to evaluate the ability of measurements of peripapillary perfusion using OCTA to distinguish healthy eyes from eyes with NA-AION.
METHODS: In this retrospective case-control study, newly diagnosed NA-AION patients and healthy controls matched at a ratio of 1:3 by gender and age (±5 years) were enrolled from 1 September 2020 to 30 June 2021. Peripapillary vessel density (pVD) was examined based on the area of vessels by means of a 4.5 mm OCTA scan. In addition, peripapillary retinal nerve fiber layer (pRNFL) thickness was obtained from structural optical coherence tomography (OCT), as was the area under the receiver operating characteristic (ROC) curve (AUC).
RESULTS: A total of 29 eyes from 28 cases with NA-AION and 99 healthy eyes from 68 participants were imaged. All participants were Chinese. The NA-AION group showed a significant reduction of the pVD (P<0.001), while all subregions of pRNFL thickness were prominent in all 8 quadrants (P>0.05). The pVD of the optic disc in the superior temporal (ST) region showed better diagnostic accuracy (AUC =0.86) in discriminating the NA-AION group from healthy controls. After adjusting for confounders, ST was independently associated with the presence of NA-AION [odds ratio (OR) =0.971, 95% confidence interval (CI): 0.943-0.990, P=0.048].
CONCLUSIONS: Decreased pVD was detected by non-invasive measurements of OCTA in the eyes of NA-AION patients. This finding may reveal an association between the ST region and the presence of NA-AION. The pVD may have potential diagnostic ability and may serve as an additional biomarker in the management of the disease. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Non-arteritic anterior ischemic optic neuropathy (NA-AION); optical coherence tomography (OCT); optical coherence tomography angiography (OCTA); peripapillary vessel density (pVD)

Year:  2022        PMID: 35111647      PMCID: PMC8739086          DOI: 10.21037/qims-21-800

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  30 in total

1.  Optical coherence tomography angiography in acute non-arteritic anterior ischaemic optic neuropathy.

Authors:  Sourabh Sharma; Marcus Ang; Raymond P Najjar; Chelvin Sng; Carol Y Cheung; Annadata V Rukmini; Leopold Schmetterer; Dan Milea
Journal:  Br J Ophthalmol       Date:  2017-01-05       Impact factor: 4.638

2.  Evaluation of acute anterior ischaemic optic neuropathy using diffusion tensor imaging.

Authors:  Binghua Fang; Qiang Liu; Jinyan Wang; Lu Yu; Xugang Liu; Ping Ma; Bojun Zhao
Journal:  Clin Exp Optom       Date:  2019-05-23       Impact factor: 2.742

Review 3.  Optic neuritis: differential diagnosis.

Authors:  S Bianchi Marzoli; V Martinelli
Journal:  Neurol Sci       Date:  2001-11       Impact factor: 3.307

4.  Mapping the visual field to the optic disc in normal tension glaucoma eyes.

Authors:  D F Garway-Heath; D Poinoosawmy; F W Fitzke; R A Hitchings
Journal:  Ophthalmology       Date:  2000-10       Impact factor: 12.079

5.  Nonarteritic anterior ischemic optic neuropathy and tobacco smoking.

Authors:  Sohan Singh Hayreh; Jost B Jonas; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2007-04       Impact factor: 12.079

6.  Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2008-05-27       Impact factor: 12.079

7.  Combined etiology for bilateral and simultaneous optic neuropathy in a patient with ciancobalamin deficit and hepatitis C treated with peg-interferon and ribavirin.

Authors:  Anca Delia Pantalon; Ciprian Danielescu; Dorin Chiseliță
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep

Review 8.  The role of Optical Coherence Tomography in optic neuropathies.

Authors:  Raluca Eugenia Iorga; Andreea Moraru; Manuela Ramona Ozturk; Dănuţ Costin
Journal:  Rom J Ophthalmol       Date:  2018 Jan-Mar

Review 9.  Optical coherence tomography angiography in neuro-ophthalmology: Current clinical role and future perspectives.

Authors:  Amar Pujari; Karthika Bhaskaran; Pradeep Sharma; Pallavi Singh; Swati Phuljhele; Rohit Saxena; Shorya Vardhan Azad
Journal:  Surv Ophthalmol       Date:  2020-11-03       Impact factor: 6.048

10.  Approaches to Potentiated Neuroprotective Treatment in the Rodent Model of Ischemic Optic Neuropathy.

Authors:  Zara Mehrabian; Yan Guo; Neil R Miller; Amanda D Henderson; Steven Roth; Steven L Bernstein
Journal:  Cells       Date:  2021-06-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.